472
Participants
Start Date
December 2, 2024
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Apixaban 2.5 MG PO BID
Patients randomized to the treatment arm will be given Apixaban 2.5 mg twice daily and DAPT (aspirin (75 mg) + clopidogrel (75 mg)) for four weeks in addition to other guideline directed medical therapy (GDMT). After 4 weeks, treatment group will be switched to DAPT.
Control (Standard treatment)
DAPT plus guideline directed medical therapy
RECRUITING
NICVD Pakistan, Karachi
National Institute of Cardiovascular Diseases, Pakistan
OTHER